The Future of e-Clinical Trial Solutions - Market Forecasts to 2015, Competitive Benchmarking and Case Studies - new market repo

The Future of e-Clinical Trial Solutions - Market Forecasts to 2015, Competitive Benchmarking and Case Studies - new market report released

2010-04-19 06:35:01 - The Future of e-Clinical Trial Solutions - Market Forecasts to 2015, Competitive Benchmarking and Case Studies - a new market research report on companiesandmarkets.com


Summary

The Future of e-Clinical Trial Solutions - Market Forecasts to 2015, Competitive Benchmarking and Case Studies provides key data and analysis of the major factors affecting the market for e-Clinical trial solutions in the pharmaceuticals industry. The report also analyzes the strengths, weaknesses, opportunities and threats in the e-Clinical trial solutions market and the key market drivers and barriers to the adoption of e-Clinical trial solutions in the industry.

The report is based on proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts.

Scope

The scope of this report includes:

• Detailed market characterization including market size and technology adoption, and forecasts until 2015.
• Data and analysis on the e-clinical trial solutions market in the leading geographies of the world – the US, Europe and Asia Pacific.
• Analysis and review of the key events and milestones that will impact the future of the global e-clinical trial solutions market. Each trend is independently researched to provide qualitative analysis of its implications.
• Insightful review of key industry drivers, restraints and challenges which are likely to impact the global e-clinical trial solutions market in the long run.
• Case Studies on cost cutting in clinical trials for clinical trial management systems, clinical supply chain management systems, clinical data management systems, intellectual voice response systems, e-diaries and standardization.
• The report also covers information on the leading market players and the competitive landscape. Key companies covered include Oracle Corporation, SAS, Clinplus, Phase Forward, Perceptive Informatics and Omnicomm systems.

Reasons to buy

The report will enhance your decision making capability and will allow you to:

• Develop business strategies by understanding the trends shaping and driving the e-clinical trial solutions market.
• Drive revenues by understanding key trends, innovative products and technologies, market segments
 and companies likely to impact the e-clinical trial solutions market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
• What’s the next big thing in the e-clinical trial solutions market landscape?
– Identify, understand and capitalize.

Click for report details: http://www.companiesandmarkets.com/Summary-Market-Report/the-future-of-e-clinical-trial-solutions-market-forecasts-to-2015,-competitive-benchmarking-and-case-studies-191899.asp?prk=49a4f456d1c9a48baf89be374b547813

Suggested Articles

Gilead Sciences is paying Nurix $45 million upfront in a deal that could reach $2.3 billion in value if all milestones are met and royalties realized.

In mice, Kymera's lead drug promoted tumor regression, both on its own and in combination with BTK inhibitor Imbruvica.

The report features testimony that some NHS bodies are “actively instructed not to deal with industry by their local leadership.”